Funding Opportunities European Commission - Horizon 2020 Wallenberg Foundations National Institutes of Health NIH Research Professional Anna Lobell - Krister Halldin - Anders Alderborn - Carolina Rydin - Sofia Wretblad - Ulrika Huss Melin Swedish grants • Government, private • Centralized proposals • Evaluations Web • Research Professional • Call portal • Manuals, forms Research Officers European Union • Identify calls • Proposal, negotiation • Implementation Research Officers Financial Unit EU Research Officers Financial Issues • Budget calculation • Financial reporting • Audit UU ”Grants Office” Financial Unit Legal Issues • Contract • IPR • Copyright Legal Unit American grants • NIH etc • Proposals • Reporting Research Officers Innovation & patent • Patent • Commersialisation • Business collaborations UU Innovation Comparison of funding agencies 2013 Millions of SEK 4500 4000 3500 3000 2500 2000 1500 1000 500 0 Årsrapport 2014 UKÄ Income MedFarm 2010-12 (tkr) ongoing and new contracts Agency (sorted on size 2012) 2010 2011 2012 140 232 151 413 167 099 Cancerfonden 52 801 57 843 51 694 EU (FP7, exkl ERC) 18 025 31 044 44 967 Formas 17 669 23 415 35 301 K&A Wallenberg Stiftelse 27 586 23 236 25 192 Vinnova 38 285 22 718 24 386 0 0 23 755 SIDA 19 765 18 591 19 378 SSF 22 069 22 359 21 023 4 353 10 257 12 454 FAS 11 740 6 019 8 880 Others (privata stiftelser o fonder, amerikanska, företag mm) 145939 169588 158976 Totalt 498455 536482 593105 Vetenskapsrådet ERC (FP7) Uppsala Akademiförvaltning 4 EU Framework Programmes • To strengthen European competitiveness, economic growth and employment • Based on “Knowledge Triangle” • Programmes: FP1 to FP7, 1984 – 2013 Horizon 2020, 2014 – 2020 Research & Technology Knowledge triangle Education Innovation Main goals 1. Strengthen the EU’s position in science – Boost top-level research 2. Strengthen European industry, in particular small companies (SMEs) – Greater access to capital and support for SMEs – Remove obstacles in industrial innovation 3. Address major European concerns (“societal challenges”) – Health problems, aging population, food safety, environment etc – Bridge the gap between research, healthcare and market 2014-2020, €80 billion 39% 3. Societal Challenges 32% 1. Excellent Science 2. Industrial leadership HORIZON 2020 21% • • • • European Research Council Marie Skłodowska-Curie Actions Future and Emerging Technologies Research Infrastructures • Health, demographic change and well-being • Food security, sustainable agriculture and forestry, marine and maritime and inland water research, and the bioeconomy • Secure, clean and efficient energy • Smart, green and integrated transport • Climate action, environment, resource efficiency and raw materials • Europe in a changing world - inclusive, innovative and reflective societies • Secure societies - protecting freedom and security of Europe and its citizens 3. Societal Challenges 1. Excellent Science 2. Industrial leadership HORIZON 2020 • Enabling and industrial technologies • Innovation in SME • Access to Risk Finance Prio 1 - Excellent Science • European Research Council (ERC) • Marie Skłodowska-Curie Actions (MSCA) • Future and Emerging Technologies (FET) • Research Infrastructures (RI) ERC (European Research Council) • Basic frontier research, “bottom-up” (like VR) • Project types: 1. Starting Grant 2-7 years from dissertation, ≤1.5 M€ over 5 years 2. Consolidator Grant 8-12 years from dissertation, ≤2 M€ over 5 years 3. Advanced Grant ≤2,5 (3,5) M€ over 5 years 4. Synergy Grant 2 - 4 researchers, ≤15 M€ over 5 years 5. Proof of Concept ≤150 k€ over 1 year Bridge gap between research and a marketable innovation Can be used as recruitment instrument from any country ERC (European Research Council) • Basic frontier research, “bottom-up” (like VR) • Project types: 1. Starting Grant 2-7 years from dissertation, ≤1.5 M€ over 5 years 2. Consolidator Grant 8-12 years from dissertation, ≤2 M€ over 5 years 3. Advanced Grant ≤2,5 (3,5) M€ over 5 years 4. Proof of Concept Grant ≤150 k€ over 1 year For ERC Grant holders to investigate innovation potential Can be used as recruitment instrument from any country Marie Skłodowska-Curie Actions (People in FP7) • Education, career development for researchers • Mobility within, to and outside Europe • Broadened interaction between industry and academia Bottom-up programmes Marie Skłodowska-Curie Actions • IF – Individual Fellowships – Research in an (another) EU country (1-2 years) – Research outside EU (1-2 years) and within EU again (1 year) Researcher • ITN – Innovative Training Networks – European “Research Training school” (5 – 10 partners) - ETN – Joint doctorate between Universities - EJD – Industry doctorate (in conjunction with university) - EID • RISE – Research and Innovation Staff Exchange – Knowledge exchange by two-way secondments Can be used as recruitment instrument from any country PhD stud, Researcher PhD stud, Researcher, Lab staff Future Emerging Technologies (FET) • Collaborative research to support radically new technological possibilities to “shape the future technology landscape” • Three lines: FET Open FET Proactive FET Flagships Early-stage, visionary new ideas (bottom-up) Based on challenges Large-scale initiatives in areas of European interest (top-down) Infrastructures • Create and coordinate European facilities, resources and services for research and innovation, e.g. – Equipment, biobanks, databases • Single site, distributed or virtual • Based on ESFRI roadmap Top-down programme ESFRI = European Strategy Forum on Research Infrastructures Prio 2 – Industrial leadership • Leadership in enabling and industrial technologies • Innovation in SME • Access to Risk Finance Leadership in enabling and industrial technologies • Collaborative projects to build industrial leadership within prioritized areas: – – – – – – ICT (Information and Communication Technologies) Nanotechnologies Advanced materials Biotechnology Advanced manufacturing and processing Space • Bridge the gap between research and marketable products and services Top-down programme (needs in industry) Innovation in SME • Funding to SMEs, entrepreneur coaching, IPR helpdesk etc May involve collaboration with University Access to Risk Finance • Loans, risk finance, bank guarantees to companies Prio 3 – Societal challenges • Health, demographic change and well-being • Food security, sustainable agriculture and forestry, marine and maritime and inland water research, and the bioeconomy • Secure, clean and efficient energy • Smart, green and integrated transport • Climate action, environment, resource efficiency and raw materials • Europe in a changing world - inclusive, innovative and reflective societies • Secure societies - protecting freedom and security of Europe and its citizens Funding schemes • Research and Innovation Action • Coordination and support – E.g. networking, support services, standardisations • Innovation Action – Close-to-market research • SME instrument – Tailored support to SMEs to develop innovative ideas • Fast track to innovation – Short project to speed up time from idea to market • Prizes • ERA-NET – Applied for by national funders Research and Innovation Action • Collaborations between academia, industry and healthcare • ≥3 (often 5 – 15) partners from ≥3 countries – Participate as coordinator or partner • Project budget ≈2 – 6 M€ (20M€) • Three evaluation criteria: 1. 2. 3. Science Impact Implementation ”Top-down” program. SMEs often important What is different from FP7? • Health => Health, demography and wellbeing • Broader topics => greater freedom to suggest solutions • More emphasis on bridging the gap between academia, healthcare and market – Open innovation – Higher participation of industry, healthcare and authorities – Clinical research more important • Stronger emphasis on expected impact – Correlate to EU strategies Important with networking! Funding rates • 100% of direct costs • 25% overhead However, companies in Innovation actions: • 70% of direct costs • 25% OH More Information http://ec.europa.eu/research/participants/portal 25 • • • • European Research Council Marie Skłodowska-Curie Actions Future and Emerging Technologies Research Infrastructures • Health, demographic change and well-being • Food security, sustainable agriculture and forestry, marine and maritime and inland water research, and the bioeconomy • Secure, clean and efficient energy • Smart, green and integrated transport • Climate action, environment, resource efficiency and raw materials • Europe in a changing world - inclusive, innovative and reflective societies • Secure societies - protecting freedom and security of Europe and its citizens 3. Societal Challenges 1. Excellent Science COST • Enabling and industrial technologies • Innovation in SME • Access to Risk Finance 2. Industrial leadership EIT European Institute of innovation & Technology EuroStars 2 Partnership Programs, PPP, JPI, JTI (e.g. IMI 2) JRC Joint Research Centre HORIZON 2020 Innovative Medicines Initiative 2 (IMI 2) • Cooperation between the commission and drug industry (via EFPIA) = PPP – Possibly extended into other areas of life science in IMI2 • “Pre-competitive” research for improved drugs – E.g. clinical trial design, new antibiotics, common stem cell bank • ≥3 (often 5 – 15) partners from ≥3 countries www.imi.europa.eu ”Top-down” program COST • COST = Network projects within 36 COST countries • Funding for project meetings, conferences, travel, accommodation, (not research) • Strengthen cooperation and defragmentation in Europe • Capacity building by promoting early-career researchers www.cost.eu ”Bottom-up” program Upcoming deadlines Program Deadline Personalising health and care ERC Advanced Grant IMI2 (T1DM therapy, macular degeneration and diabetic retinopathy) Marie Curie ITN ERC Starting Grant Personalising health and care ERC Consolidator Grant October 14 October 21 November 12 January 13 February 3 February 24 March 12 Newsletter about upcoming calls Anders Alderborn, PhD, Assoc Prof Contact and support EU [email protected] 018 - 471 2577 070 - 425 0754 Krister Halldin, PhD [email protected] 018 - 471 2587 070 - 425 0753 Anna Lobell, PhD, Assoc Prof [email protected] 018 - 471 5086 070 - 425 0706 Offices at BMC, A2 floor 1 • • • • • • Find EU programme Apply Negotiate Implement project Report Influence upcoming calls https://mp.uu.se/web/info/forska/forskarservice 32 33 35 Note • VR Grants for international recruitment of leading researchers (<15 mkr/year, 10 years) • VR International Career Grants, April X • Wallenberg Academy Fellows, Jan X (Head of Dept nominates) • Workshop for Young Researchers applying to VR (start up seminar 3 Dec) • FORTE – more focus on health/welfare issues 38 VR Medicin och hälsa 2013 Summa projektbidrag 2008 – 2013 (inkl. unga forskare) i kr för hela anslagsperioden (3 – 6 år), de fem största lärosätena 600,000,000 500,000,000 400,000,000 KI kr LU kr 300,000,000 GU kr UU kr UmU kr 200,000,000 100,000,000 0 2008 2009 2010 2011 2012 2013 VR MH 2013 – Projektbidrag (inkl. unga forskare), antal ansökningar och antal beviljade (12 lärosäten) 600 500 Antal 400 300 200 100 0 KI GU LU UU UmU LiU SU SLU KTH CTH SLL HiB Beviljade Projekt 103 30 39 22 15 7 3 2 0 2 1 1 Ansökta Projekt 553 198 235 165 105 73 22 9 7 4 4 1 VR MH 2013 – Projektbidrag unga forskare, antal ansökningar och antal beviljade (12 lärosäten) 180 160 140 Antal 120 100 80 60 40 20 0 KI GU LU UU UmU LiU SU SLU KTH CTH SLL HiB Beviljade Projekt-bidrag - Unga forskare 15 1 5 2 3 0 0 0 0 0 0 0 Ansökta Projektbidrag - Unga forskare 167 57 76 47 25 12 6 3 1 1 0 0 VR MH 2011-2013 Projektbidrag unga forskare (alla) Antal beviljade MH Unga forskare Summa kronor 2011 2012 2013 KI 39 26 15 GU 14 9 1 34 800 000 43 400 000 10 000 000 LU 12 13 5 30 700 000 58 381 000 35 945 000 UU 6 3 2 13 800 000 11 050 000 11 950 000 UmU 7 2 3 16 350 000 7 324 000 18 544 000 LiU 2 2 4 800 000 6 650 000 SU 2 7 800 000 SLU 1 2 100 000 ÖU 1 1 800 000 Summa antal beviljade, summa belopp 84 55 26 2011 2012 2013 95 500 000 111 572 000 102 077 000 207 650 000 238 377 000 178 516 000 Contact and support Carolina Rydin, PhD [email protected] 018 - 471 2578 0701 - 67 93 14 Sofia Wretblad, PhD National funding bodies - Centrally coordinated applications - Applications signed by the Vice-Chancellor [email protected] 018 - 471 7137 070 - 425 0412 Ulrika Huss Melin, PhD [email protected] 018 - 471 1893 070 - 425 0188 Offices at St: Olofsgatan The Wallenberg Foundations (KAW, MMW, MAW) US Funding Opportunities (NIH, NSF, USAID etc)